Status:

NOT_YET_RECRUITING

Evaluation of the Access to Healthcare Service

Lead Sponsor:

University Hospital, Rouen

Conditions:

Emergency Service, Hospital

Eligibility:

All Genders

18+ years

Brief Summary

The Healthcare Access Service (SAS) of the Emergency Department of the CHG du Havre is a telephone regulation (i.e., orientation) service for users of Le Havre. Access to this service, during a call, ...

Detailed Description

The SAS represents an evolution of SAMU medical regulation, no longer based solely on emergency medical assistance (the standard regulation system), but also combining it with outpatient medical regul...

Eligibility Criteria

Inclusion

  • For the primary analysis and secondary outcome measure 1:
  • All calls to 116-117 or 15 in the Le Havre area over the 40 study periods,
  • Non-opposition. Patients with a life-threatening emergency will be included in the primary analysis, even though there will be no pseudo-randomization of the systems for them. They are therefore included in the study.
  • For the secondary analysis on patient compliance with the referral given by the regulating physician (secondary objective 2):
  • Non-opposition of patients who used the SNP call for the primary analysis,
  • Randomly selected by sampling calls to 116-117 or 15 made over the study periods defined by the protocol.
  • For the qualitative component:
  • Major,
  • No opposition from regulators and major effectors of the SAS
  • Or No opposition from adult health patients in the Le Havre area who have used the unscheduled care system (outpatient or inpatient).

Exclusion

  • For the primary analysis and secondary objective 1:
  • Refusal to participate,
  • Non-French speaking.
  • For the secondary analysis on patient compliance with the referral given by the regulating physician (secondary objective 2) and for the qualitative component:
  • Minor caller
  • Refusal to participate (patient or caller or both),
  • Non-French speaking (caller)
  • Only for adult healthcare users in the Le Havre area included in the qualitative component: Not having the independent capacity to use the SNP. Non-use of the SAS will not be a criterion for exclusion.

Key Trial Info

Start Date :

December 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

9280 Patients enrolled

Trial Details

Trial ID

NCT07207499

Start Date

December 1 2025

End Date

June 1 2027

Last Update

October 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Le Havre Hospital Group,

Le Havre, France, 76083